EXTON, Pa., April 30 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Ninth Annual JMP Securities Research Conference at The Ritz-Carlton in San Francisco on Monday, May 10, 2010.
Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, beginning at approximately 12:30 p.m. (PT). To hear the live webcast of the Kensey Nash presentation at the Ninth Annual JMP Securities Research Conference, go to http://www.wsw.com/webcast/jmp10/knsy/ and access the conference link. The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 12:30 p.m. (PT) on Monday, May 10, 2010.
About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials. The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including, the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.
|SOURCE Kensey Nash Corporation|
Copyright©2010 PR Newswire.
All rights reserved